Considering Aspirin: 8 Questions on Primary CVD Prevention

September 2, 2020
Aparna Sajja, MD

Seth Martin, MD, MHS

Dr. Martin is an assistant professor at the Ciccarone Center for the Prevention of Heart Disease at the Johns Hopkins University School of Medicine.

The role of aspirin in primary prevention of CV disease changed for good with results from 3 pivotal trials. Do you recall results and recommendations? Find out.

Remember ARRIVE, ASCEND, and ASPREEthe 3 pivotal randomized controlled trials conducted in nearly 50,000 patients in a variety of possible scenarios that changed the place of aspirin in primary cardiovascular disease prevention for good?

Try this 8-question quiz as a refresher on the study outcomes, the recommendations and patient selection for aspirin use in primary prevention of CVD.